Clinical Trial Update: Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates adding fludarabine to induction therapy for patients with untreated multiple myeloma; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Fludarabine (Fludarabine)

Snippet

Sponsor: Nordic Myeloma Study Group | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN